title: Challenges of establishing new antithrombotic therapies in atrial fibrillation.
authors.affiliation: Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. connostu@phri.ca
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Connolly
authors.forename: John
authors.initials: J
authors.lastname: Eikelboom
authors.forename: Martin
authors.initials: M
authors.lastname: O'Donnell
authors.forename: Janice
authors.initials: J
authors.lastname: Pogue
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D000818:Animals; D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D015507:Drugs, Investigational; D005343:Fibrinolytic Agents; D014859:Warfarin